Literature DB >> 24277334

Prostaglandin E1-induced Catalepsy in the Rat: Role of Putative Neutrotransmitters.

S K Bhattacharya1, P J Rao, D Bhattacharya.   

Abstract

Prostaglandin E1 (PGE1) produced dose-related catalepsy in rats when administered intracerebroventricularly. PGE1 induced catalepsy was significantly inhibited after pretreatment with pharmacological agents known to attenuate central serotonergic and cholinergic activity. It was also inhibited by PGF2α and naloxone. On the contrary, treatments enhancing central dopaminergic activity also reduced the cataleptic effect of PGE1. The results suggest that PGE1 induces catalepsy in rats by modulating activity of central neurotransmitters.

Entities:  

Year:  1984        PMID: 24277334     DOI: 10.1023/A:1016377431257

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

Review 1.  Prostaglandins and the central nervous system.

Authors:  F Coceani
Journal:  Arch Intern Med       Date:  1974-01

2.  p-Chlorophenylalanine: a specific depletor of brain serotonin.

Authors:  B K Koe; A Weissman
Journal:  J Pharmacol Exp Ther       Date:  1966-12       Impact factor: 4.030

3.  Possible importance of 5-hydroxytryptamine in neuroleptic-induced catalepsy in rats [proceedings].

Authors:  C J Carter; C J Pycock
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

4.  Cannabis-induced catalepsy in mice: role of putative neurotransmitters.

Authors:  P Ghosh; R Bose; S K Bhattacharya
Journal:  Indian J Med Res       Date:  1980-10       Impact factor: 2.375

5.  Morphine-induced catalepsy in rat: Role of putative neurotransmitters.

Authors:  R Bose; S K Bhattacharya
Journal:  Indian J Med Res       Date:  1979-08       Impact factor: 2.375

6.  Antagonism of some central pharmacological actions of prostaglandin E1 by prostaglandin F2alpha in rat.

Authors:  S K Bhattacharya; P K Debnath; A K Sanyal
Journal:  Indian J Med Res       Date:  1978-05       Impact factor: 2.375

7.  Effect of prostaglandin E 2 on central and peripheral catecholamine neurons.

Authors:  S Bergström; L O Farnebo; K Fuxe
Journal:  Eur J Pharmacol       Date:  1973-03       Impact factor: 4.432

8.  Possible interrelationship between the antinociceptive effect of morphine and brain 5-hydroxytryptamine in albino rats.

Authors:  A K Sanyal; D N Srivastava; S K Bhattacharya
Journal:  Indian J Med Res       Date:  1981-05       Impact factor: 2.375

9.  Prostaglandins in the brain of rats given, acutely, and chronically, a hyperthermic dose of met-enkephalin.

Authors:  G M Scoto; C Spadaro; S Spampinato; R Arrigo-Reina; S Ferri
Journal:  Psychopharmacology (Berl)       Date:  1979-01-31       Impact factor: 4.530

10.  The antinociceptive effect of intracerebroventricularly administered prostaglandin E1 in the rat.

Authors:  A K Sanyal; D N Srivastava; S K Bhattacharya
Journal:  Psychopharmacology (Berl)       Date:  1979-01-31       Impact factor: 4.530

View more
  5 in total

1.  Stress by restraining potentiates morphine catalepsy in rats.

Authors:  S K Bhattacharya; S S Parmar
Journal:  Experientia       Date:  1985-12-15

2.  Role of putative neurotransmitters in bradykinin-induced catalepsy in the rat.

Authors:  S K Bhattacharya; P J Rao; S J Brumleve; S S Parmar
Journal:  Pharm Res       Date:  1986-06       Impact factor: 4.200

3.  Prostaglandins and central serotonergic activity in the rat.

Authors:  S K Bhattacharya
Journal:  Pharm Res       Date:  1985-09       Impact factor: 4.200

4.  Effect of chronic administration of low dose aspirin on haloperidol induced catalepsy in rats.

Authors:  Arijit Ghosh; V R Dhumal; Abhijeet V Tilak; Amarinder Singh; Meghna Pandey; Abhijit A Bondekar
Journal:  J Pharmacol Pharmacother       Date:  2011-07

5.  Neuroprotective effects of Nigella sativa extracts during germination on central nervous system.

Authors:  Mohammad Hayatul Islam; Iffat Zareen Ahmad; Mohammad Tariq Salman
Journal:  Pharmacogn Mag       Date:  2015-05       Impact factor: 1.085

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.